Filing metadata

Accession number
0001209191-19-033497
Form type
Form 3
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
May 30, 2019
Reporting period
Apr 15, 2019
Description
Initial ownership

Explore SEC Filings Hub